Michigan Board of Pharmacy Approved Continuing Education Programs Report December 2025
CE Approval for Medicare Denial Trends by MyMichigan
Trusted by teams at
Description
The Michigan Board of Pharmacy approved MyMichigan Medical Center -Midland to provide a 1-hour CE program on Medicare denial trends for erythropoiesis-stimulating agents to pharmacists and pharmacy technicians from February 18, 2026 through February 28, 2029.
Contract Details
Vendor
MYMICHIGAN MEDICAL CENTER -MIDLAND
Agency
Michigan Department L&RA|Pharmacy Board, MI
Contract Type
PROFESSIONAL_SERVICES
Document Date
December 17, 2025
Contract Term
February 18, 2026 – February 28, 2029
Renewal Date
2029-02-28
Renewal Info
Approval is valid until February 28, 2029. Renewal will require a new Board application post-expiry.
More from MYMICHIGAN MEDICAL CENTER -MIDLAND
Related Contracts
More from Michigan Department L&RA|Pharmacy Board
Michigan Board of Pharmacy Approved Continuing Education Programs Report December 2025
Michigan Board of Pharmacy Approved Continuing Education Programs Report December 2025
Michigan Board of Pharmacy Approved Continuing Education Programs Report December 2025
Michigan Board of Pharmacy Approved Continuing Education Programs Report December 2025
Michigan Board of Pharmacy Approved Continuing Education Programs Report December 2025
Want to learn more?
Get alerts on contract renewals, new awards, and vendor activity.
Bring us your territory.
We'll show you what is forming.
See live SLED buying signals, source docs, decision-makers, contract context, and the next step into your CRM or pipeline.